A citation-based method for searching scientific literature

Halis Kaan Akturk, Janet K Snell-Bergeon, Amanda Rewers, Leslie J Klaff, Bruce W Bode, Anne L Peters, Timothy S Bailey, Satish K Garg. Diabetes Technol Ther 2018
Times Cited: 19







List of co-cited articles
129 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial.
Bruce W Bode, Janet B McGill, Daniel L Lorber, Jorge L Gross, P C Chang, David B Bregman. Diabetes Care 2015
46
52

Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (onset 1).
David Russell-Jones, Bruce W Bode, Christophe De Block, Edward Franek, Simon R Heller, Chantal Mathieu, Athena Philis-Tsimikas, Ludger Rose, Vincent C Woo, Anne Birk Østerskov,[...]. Diabetes Care 2017
84
31

Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial.
Wendy Lane, Timothy S Bailey, Gregg Gerety, Janusz Gumprecht, Athena Philis-Tsimikas, Charlotte Thim Hansen, Thor S S Nielsen, Mark Warren. JAMA 2017
114
26


Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long).
Bernard Zinman, Athena Philis-Tsimikas, Bertrand Cariou, Yehuda Handelsman, Helena W Rodbard, Thue Johansen, Lars Endahl, Chantal Mathieu. Diabetes Care 2012
224
26

Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.
Carol Wysham, Anuj Bhargava, Louis Chaykin, Raymond de la Rosa, Yehuda Handelsman, Lone N Troelsen, Kajsa Kvist, Paul Norwood. JAMA 2017
139
26

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis.
Sumeet R Singh, Fida Ahmad, Avtar Lal, Changhua Yu, Zemin Bai, Heather Bennett. CMAJ 2009
136
26

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
26

Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial.
H W Rodbard, B Cariou, B Zinman, Y Handelsman, A Philis-Tsimikas, T V Skjøth, A Rana, C Mathieu. Diabet Med 2013
63
26

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
Satish K Garg, Stuart A Weinzimer, William V Tamborlane, Bruce A Buckingham, Bruce W Bode, Timothy S Bailey, Ronald L Brazg, Jacob Ilany, Robert H Slover, Stacey M Anderson,[...]. Diabetes Technol Ther 2017
263
26


Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin.
Lutz Heinemann, Robert Baughman, Anders Boss, Marcus Hompesch. J Diabetes Sci Technol 2017
32
26

Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research.
Philip A Levin, Hiep Nguyen, Eric T Wittbrodt, Seoyoung C Kim. Diabetes Metab Syndr Obes 2017
50
21

Effect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus.
Sandeep Vijan, Jeremy B Sussman, John S Yudkin, Rodney A Hayward. JAMA Intern Med 2014
115
21

Glucagon-like peptide-1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis.
Sonal Singh, Eugene E Wright, Anita Y M Kwan, Juliette C Thompson, Iqra A Syed, Ellen E Korol, Nathalie A Waser, Maria B Yu, Rattan Juneja. Diabetes Obes Metab 2017
43
21

Insulin Access and Affordability Working Group: Conclusions and Recommendations.
William T Cefalu, Daniel E Dawes, Gina Gavlak, Dana Goldman, William H Herman, Karen Van Nuys, Alvin C Powers, Simeon I Taylor, Alan L Yatvin. Diabetes Care 2018
88
21


Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study.
Vanita R Aroda, Sharon L Edelstein, Ronald B Goldberg, William C Knowler, Santica M Marcovina, Trevor J Orchard, George A Bray, David S Schade, Marinella G Temprosa, Neil H White,[...]. J Clin Endocrinol Metab 2016
151
21

Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes.
Michaela Diamant, Michael A Nauck, Rimma Shaginian, James K Malone, Simon Cleall, Matthew Reaney, Danielle de Vries, Byron J Hoogwerf, Leigh MacConell, Bruce H R Wolffenbuttel. Diabetes Care 2014
148
21

Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis.
Andrea C Tricco, Huda M Ashoor, Jesmin Antony, Joseph Beyene, Areti Angeliki Veroniki, Wanrudee Isaranuwatchai, Alana Harrington, Charlotte Wilson, Sophia Tsouros, Charlene Soobiah,[...]. BMJ 2014
54
21

Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
Hsin-Chieh Yeh, Todd T Brown, Nisa Maruthur, Padmini Ranasinghe, Zackary Berger, Yong D Suh, Lisa M Wilson, Elisabeth B Haberl, Jessica Brick, Eric B Bass,[...]. Ann Intern Med 2012
285
21

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study.
H Yki-Järvinen, R Kauppinen-Mäkelin, M Tiikkainen, M Vähätalo, H Virtamo, K Nikkilä, T Tulokas, S Hulme, K Hardy, S McNulty,[...]. Diabetologia 2006
300
21

Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Maria Ida Maiorino, Paolo Chiodini, Giuseppe Bellastella, Annalisa Capuano, Katherine Esposito, Dario Giugliano. Diabetes Care 2017
57
21

Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes.
Francesca Porcellati, Paola Lucidi, Patrizia Cioli, Paola Candeloro, Anna Marinelli Andreoli, Stefania Marzotti, Maura Ambrogi, Geremia B Bolli, Carmine G Fanelli. Diabetes Care 2015
24
21








New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4).
Philip D Home, Richard M Bergenstal, Geremia B Bolli, Monika Ziemen, Maria Rojeski, Melanie Espinasse, Matthew C Riddle. Diabetes Care 2015
113
21

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
21

Long-term treatment with metformin in type 2 diabetes and methylmalonic acid: Post hoc analysis of a randomized controlled 4.3year trial.
Mattijs Out, Adriaan Kooy, Philippe Lehert, Casper A Schalkwijk, Coen D A Stehouwer. J Diabetes Complications 2018
23
21

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Steven C Griffen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde. Lancet Diabetes Endocrinol 2017
156
21

Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis.
Matteo Monami, Niccolò Marchionni, Edoardo Mannucci. Diabetes Res Clin Pract 2008
129
21

Dose-response effects of insulin glargine in type 2 diabetes.
Zhihui Wang, Maka S Hedrington, Nino Gogitidze Joy, Vanessa J Briscoe, M Antoinette Richardson, Lisa Younk, Wendell Nicholson, Donna B Tate, Stephen N Davis. Diabetes Care 2010
26
21


Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Steven P Marso, Darren K McGuire, Bernard Zinman, Neil R Poulter, Scott S Emerson, Thomas R Pieber, Richard E Pratley, Poul-Martin Haahr, Martin Lange, Kirstine Brown-Frandsen,[...]. N Engl J Med 2017
283
21



Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations.
Wendy L Bennett, Nisa M Maruthur, Sonal Singh, Jodi B Segal, Lisa M Wilson, Ranee Chatterjee, Spyridon S Marinopoulos, Milo A Puhan, Padmini Ranasinghe, Lauren Block,[...]. Ann Intern Med 2011
381
21


Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
Richard M Bergenstal, Satish Garg, Stuart A Weinzimer, Bruce A Buckingham, Bruce W Bode, William V Tamborlane, Francine R Kaufman. JAMA 2016
300
21

New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2).
Hannele Yki-Järvinen, Richard Bergenstal, Monika Ziemen, Marek Wardecki, Isabel Muehlen-Bartmer, Emmanuelle Boelle, Matthew C Riddle. Diabetes Care 2014
178
21

State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.
Nicole C Foster, Roy W Beck, Kellee M Miller, Mark A Clements, Michael R Rickels, Linda A DiMeglio, David M Maahs, William V Tamborlane, Richard Bergenstal, Elizabeth Smith,[...]. Diabetes Technol Ther 2019
556
21

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
617
21

Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials.
Julio Rosenstock, Jan Marquard, Lori M Laffel, Dietmar Neubacher, Stefan Kaspers, David Z Cherney, Bernard Zinman, Jay S Skyler, Jyothis George, Nima Soleymanlou,[...]. Diabetes Care 2018
116
21


Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
209
21


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.